Medical Genetics

Understanding and Navigating Fabry Disease

At a Glance

Fabry disease is a rare genetic condition caused by a missing or dysfunctional alpha-galactosidase A enzyme. This leads to fatty substance buildup that stresses the heart, kidneys, and nervous system. Proactive treatments exist, including enzyme replacement therapy, to protect your future health.

Welcome. Receiving a diagnosis of Fabry disease can feel like being dropped into a foreign country without a map. It is normal to feel overwhelmed, anxious, or even relieved to finally have a name for your symptoms. This guide is designed to help you find your footing, translate complex medical jargon into plain language, and empower you to build the best possible care team.

Fabry disease is a rare genetic condition where a specific “recycling tool” in your cells—the alpha-galactosidase A enzyme—is either missing or not working well ^[1]. Over time, this causes fatty substances to build up and stress vital organs like the heart, kidneys, and nervous system ^[2]. But the most important thing you need to know right now is that treatment exists, and proactive management can protect your future ^[3].

Please use the links below to navigate the different sections of this guide.

Start Your Journey Here

Validation & Orientation: Understanding Fabry Disease

Newly diagnosed with Fabry disease? Learn what causes this rare lysosomal storage disorder, why diagnostic delays happen, and what treatments are available.

Symptoms & Misdiagnoses of Fabry Disease

Learn to recognize the early symptoms of Fabry disease in children and adults. Understand common misdiagnoses like IBS and why genetic testing is vital.

Biology, Genetics & Subtypes of Fabry Disease

Understand the biology and genetics of Fabry disease. Learn about the GLA gene, X-linked inheritance, and the difference between classic and late-onset types.

Testing & Treatment

Diagnosis & Understanding Your Lab Reports

Learn how Fabry disease is diagnosed. Understand key lab reports including alpha-Gal A enzyme assays, GLA gene sequencing, Lyso-Gb3 levels, and mutations.

Standard of Care Treatment for Fabry Disease

Learn about standard treatments for Fabry disease, including IV Enzyme Replacement Therapy (ERT) and oral chaperone therapy (migalastat) for amenable mutations.

Living with Fabry Disease

Building Your Care Team & First Visit Prep

Learn how to build a multidisciplinary care team for Fabry disease. Discover the essential specialists, what to bring to your first visit, and questions to ask.

Survivorship, Monitoring, and Daily Management

Learn how to manage Fabry disease daily and monitor your long-term health. Discover expert tips for symptom relief, pediatric transition, and organ tracking.

Common questions in this guide

What is Fabry disease?

Fabry disease is a rare genetic condition where your cells are missing or have a poorly working "recycling tool" called the alpha-galactosidase A enzyme. Without this enzyme, fatty substances build up and stress vital organs over time.

Is there a treatment for Fabry disease?

Yes, treatments are available and can help protect your future health. Depending on your specific genetic mutation, options may include intravenous enzyme replacement therapy or oral chaperone therapy.

What organs are most affected by Fabry disease?

The buildup of fatty substances primarily stresses and can damage the heart, kidneys, and the nervous system over time. Regular monitoring of these systems is a crucial part of managing the condition.

What is the difference between classic and late-onset Fabry disease?

Fabry disease mutations are generally categorized as classic or late-onset, which affects when your symptoms first appear and how the disease progresses. Your doctor can tell you which subtype you have based on your genetic testing.

What kind of doctors treat Fabry disease?

Because Fabry disease can affect multiple organ systems, your care will likely involve several specialists, such as cardiologists, nephrologists, and neurologists. It is important to ask your doctor who will act as the "quarterback" to coordinate this multidisciplinary team.

Curated prompts to bring to your next appointment.

1.What is the specific name of my genetic mutation, and is it considered classic or late-onset?
2.Who will be the 'quarterback' of my multidisciplinary care team?
3.Is my mutation amenable to oral chaperone therapy, or should we look at intravenous enzyme replacement therapy?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (3)

1
Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation.
Duarte AJ, Ribeiro D, Santos R, et al.
Stem cell research 2020; (45()):101794 doi:10.1016/j.scr.2020.101794.
PMID: 32388441
2
Current and Emerging Therapies for Lysosomal Storage Disorders.
Abelleyra Lastoria DA, Keynes S, Hughes D
Drugs 2025; (85(2)):171-192 doi:10.1007/s40265-025-02145-5.
PMID: 39826077
3
[The neurological manifestations of Fabry disease. A review].
Firsov KV, Kotov AS
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2016; (116(9)):98-105 doi:10.17116/jnevro20161169198-105.
PMID: 27735906

This page provides general overview information about Fabry disease for educational purposes. Always consult your geneticist or healthcare provider to discuss your specific diagnosis, mutation type, and treatment options.

Get notified when new evidence is published on Fabry disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents